# FDA Inspection 1229435 - Gilead Sciences, Inc. - February 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/ae4b768e-0f35-4f6a-8c5a-aa531e402a9d
Source feed: FDA_Inspections

> FDA Inspection 1229435 for Gilead Sciences, Inc. on February 12, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229435
- Company Name: Gilead Sciences, Inc.
- Inspection Date: 2024-02-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1304734 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/9a3e7cd6-2b15-48bc-bf67-45cae1e92311)
- [FDA Inspection 1159086 - 2021-12-17](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/f3390bd4-1e60-4b26-8250-0f3b5623886a)
- [FDA Inspection 1093610 - 2019-05-14](https://www.keypedia.com/records/fda_inspections/gilead-sciences-inc/baa7095b-63fe-46ee-9505-80f480e4dc34)

Company: https://www.keypedia.com/companies/gilead-sciences-inc/aef302cf-d6ca-423c-8e9a-4529b8be42ea

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b